Cargando…
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease
Mitochondria comprise the central metabolic hub of cells and their imbalance plays a pathogenic role in chronic kidney disease (CKD). Here, we studied Lon protease 1 (LONP1), a major mitochondrial protease, as its role in CKD pathogenesis is unclear. LONP1 expression was decreased in human patients...
Autores principales: | Bai, Mi, Wu, Mengqiu, Jiang, Mingzhu, He, Jia, Deng, Xu, Xu, Shuang, Fan, Jiaojiao, Miao, Mengqiu, Wang, Ting, Li, Yuting, Yu, Xiaowen, Wang, Lin, Zhang, Yue, Huang, Songming, Yang, Li, Jia, Zhanjun, Zhang, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906428/ https://www.ncbi.nlm.nih.gov/pubmed/36629048 http://dx.doi.org/10.15252/emmm.202216581 |
Ejemplares similares
-
Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
por: Miao, Mengqiu, et al.
Publicado: (2022) -
TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5
por: Wu, Mengqiu, et al.
Publicado: (2023) -
Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
por: Li, Yuting, et al.
Publicado: (2023) -
From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases
por: Zhang, Lingge, et al.
Publicado: (2023) -
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function
por: Yu, Xiaowen, et al.
Publicado: (2018)